Entera Bio Ltd. — Director's Dealing 2022

Jan 11, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: Toledano Miranda Jayne (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.98	2029-01-17	Ordinary Shares, par value NIS 0.0000769 per share (33638)		Direct

Footnotes

F1: The options vested ratably on a quarterly basis over a three-year period that commenced on December 27, 2018.